Fair Richard A.
Insider CIK 1695851 · BLCM President and CEO, Director · CLVS Director · ELVN PRESIDENT AND CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-12-11 | 2025-12-12 | 875,000 | — | $0 | 875,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2022-08-15 | 2022-08-16 | 400,000 | $1.44 | $576.0K | 400,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-08-16 | 2021-08-16 | 265,000 | — | $0 | 265,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-08-16 | 2021-08-18 | 265,000 | — | $0 | 265,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 42,223 | — | $0 | 42,223 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-12-15 | 2020-12-16 | 286,000 | — | $0 | 286,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 40,138 | — | $0 | 40,138 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | P Buy | 2020-03-17 | 2020-03-19 | 5,000 | $4.00 | $20.0K | 5,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-02-03 | 2020-02-04 | 1,257,000 | — | $0 | 1,257,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | P Buy | 2019-09-10 | 2019-09-11 | 40,000 | $1.25 | $50.0K | 66,561 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | P Buy | 2019-08-21 | 2019-08-23 | 20,000 | $0.99 | $19.8K | 26,561 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-11 | 2019-06-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-06-06 | 2019-06-07 | 28,882 | — | $0 | 28,882 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-02-01 | 2019-02-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-10-11 | 2018-10-15 | 25,848 | — | $0 | 25,848 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-07-02 | 2018-07-05 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-30 | 2017-02-01 | 500,000 | — | $0 | 500,000 | SEC↗ |